Related Experiment Video
Updated: Jan 19, 2026
Generalized Anxiety Disorder
Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders:
Paul Glue1, Shona Neehoff1, Amandine Sabadel2
1Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Background:
We previously reported that ketamine has anxiolytic effects in patients with treatment-resistant generalized anxiety and social anxiety disorders.
Aims:
The purpose of this study was to replicate our earlier report about ketamine's anxiolytic activity, using a more robust study design.
Methods:
This was a double-blind, psychoactive-controlled ascending dose study in 12 patients with treatment-resistant generalized anxiety and social anxiety disorders who were not currently depressed. Ascending doses of ketamine (0.25, 0.5, 1 mg/kg) were administered at weekly intervals, and midazolam 0.01 mg/kg, the control, was randomly inserted into the ketamine dose sequence. Assessments included ratings of anxiety and dissociation, safety and tolerability, and blood samples for ketamine pharmacokinetics and BDNF concentrations.
Results:
Improvements in anxiety ratings occurred within an hour of ketamine dosing, and persisted for up to 1 week. A dose-response profile was noted for anxiolytic effects, dissociative side effects, and changes in blood pressure and heart rate after ketamine dosing. Midazolam had minor brief effects on anxiety ratings. Ketamine was safe and well tolerated. Ketamine pharmacokinetics were correlated with dissociation ratings. Serum BDNF concentrations declined over time and were similar for all treatments.
Conclusions:
Ketamine may be a potential therapeutic option for patients with treatment-resistant generalized anxiety and social anxiety disorders.
Related Concept Videos
Generalized Anxiety Disorder
Social Anxiety Disorder
Anxiety Testing
04:20Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
08:17Reducing State Anxiety Using Working Memory Maintenance
05:52Hyponeophagia: A Measure of Anxiety in the Mouse